Invasive candidiasis is the most common critical care-associated fungal infection with a
crude mortality of~ 40–55%. Important factors contributing to risk of invasive candidiasis in …

Human fungal pathogens are attributable to a significant economic burden and mortality
worldwide. Antifungal treatments, although limited in number, play a pivotal role in …

The objectives of this study were to assess Candida spp. distribution and antifungal
resistance of candidaemia across Europe. Isolates were collected as part of the third ECMM …

Background Candida glabrata is the second leading fungal pathogen causing candidaemia
and invasive candidiasis in Europe. This yeast is recognized for its rapid ability to acquire …

In different regions worldwide, there exists an intra-and inter-regional variability in the rates
of resistance to antifungal agents in Candida glabrata, highlighting the importance of …

Objectives We evaluated the azole resistance mechanisms and epidemiology of fluconazole-
resistant Candida glabrata from a global survey. Methods A total of 2992 Candida spp …

Background Candida glabrata is the third leading cause of candidaemia in Turkey; however,
the data regarding antifungal resistance mechanisms and genotypic diversity in association …

Recognising the growing global burden of fungal infections, the World Health Organization
(WHO) established an advisory group consisting of experts in fungal diseases to develop a …

We compared the susceptibility of six commercially available antifungal agents (fluconazole,
itraconazole, voriconazole, caspofungin, micafungin, and amphotericin B) against 133 …

Objectives This study investigated the antifungal resistance rates of isolates from
candidaemia patients in 12 tertiary-care centres in Turkey. Methods A total of 1991 Candida …